MigreLief-NOW By Akeso Overview & Drug Interactions

Check For Interactions With MigreLief-NOW

Supplement: MigreLief-NOW by Akeso

MigreLief-NOW Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with MigreLief-NOW by Akeso

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
2 Capsule(s)
Maximum serving Sizes:
2 Capsule(s)
UPC/BARCODE 855586000827

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Magnesium
180 mg
Magnesium 45%
Puracol Feverfew
50 mg
Feverfew --
Cerevasc Ginger
500 mg
Ginger --
Aflapin Boswellia serrata
100 mg
Indian Frankincense --

Other Ingredients:
powdered Cellulose
Silicon Dioxide
Magnesium Stearate
Vegetable Capsule


Label Statments:


General Statements
- Where nature & medicine unite
- MigreLief-NOW can be taken as needed for fast acting cerebrovascular support during difficult times.
- Recommended Usage: Age 14-Adult: Take 3-4 capsules with food. May repeat dose in 2 hrs. (Do not exceed 8 capsules in a 24 hr. period or 4 if combining with a MigreLief daily formula.)
- Fast acting Nutritional support formula
- MigreLief Formulas are recommended by top headache doctors to provide nutritional support for migraine sufferers
Precautions
- (Do not exceed 8 capsules in a 24 hr. period or 4 if combining with a MigreLief daily formula.)
- (Do not exceed 4 capsules in a 24 hr. period or 2 if combining with a MigreLief daily formula.)
- (Do not exceed 2 capsules in a 24 hr. period.)
- Warnings: Not for use during pregnancy, lactation or by children under age 2.
- Warnings: Not for use during pregnancy, lactation or by children under age 2.
Suggested/Recommended/Usage/Directions
- Age 9-13: 1-2 capsules with food. May repeat dose in 2 hrs. (Do not exceed 4 capsules in a 24 hr. period or 2 if combining with a MigreLief daily formula.)
- Age 2-8: 1 capsule with food. May repeat dose in 2 hrs. (Do not exceed 2 capsules in a 24 hr. period.)
Formulation
- Does Not Contain: Aspirin, caffeine, yeast, milk, corn, wheat, gluten, soy, salt, artificial colorings or flavorings.
FDA Disclaimer Statement
- This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
Formula
- Triple benefits from Cerevasc, Puracol & Aflapin
- Puracol is a proprietary combination of whole leaf feverfew that contains a broad sprectrum of naturally occurring phytochemicals and a unique feverfew extract.
- Cerevasc Ginger is a proprietary combination of ginger rhizome powder and standardized ginger extract.
FDA Statement of Identity
- Dietary Supplement
Brand IP Statement(s)
- Patent # 6,500,450
- Aflapin is a registered trademark of Laila Nutraceuticals. International patents pending.

Brand Information

See all products by this brand

Distributed by:
Name Akeso Health Sciences, LLC
City Westlake Village
State CA
ZipCode 91361
Phone Number 1-800-758-8746
Email [email protected]
Web Address www.MigreLief.com/FAQs

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.